These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17109333)

  • 21. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype.
    Montoya CJ; Cataño JC; Ramirez Z; Rugeles MT; Wilson SB; Landay AL
    Clin Immunol; 2008 Apr; 127(1):1-6. PubMed ID: 18304877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic features of HIV-1-infected women on HAART at delivery.
    Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
    Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
    AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 at the immunological and T-lymphocytic virological synapse.
    Haller C; Fackler OT
    Biol Chem; 2008 Oct; 389(10):1253-60. PubMed ID: 18713012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Has HIV evolved to induce immune pathogenesis?
    Bartha I; Simon P; Müller V
    Trends Immunol; 2008 Jul; 29(7):322-8. PubMed ID: 18524680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption.
    Barqasho B; Nowak P; Tjernlund A; Kinloch S; Goh LE; Lampe F; Fisher M; Andersson J; Sönnerborg A;
    HIV Med; 2009 Feb; 10(2):94-102. PubMed ID: 19200172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
    Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
    Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation.
    Casula M; Vrisekoop N; Wit FW; de Baar MP; de Ronde A; Miedema F; Reiss P
    J Infect Dis; 2007 Aug; 196(3):371-6. PubMed ID: 17597451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection.
    Nilsson J; Kinloch-de-Loes S; Granath A; Sönnerborg A; Goh LE; Andersson J
    AIDS; 2007 Mar; 21(5):565-74. PubMed ID: 17314518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV disease progression: immune activation, microbes, and a leaky gut.
    Douek D
    Top HIV Med; 2007; 15(4):114-7. PubMed ID: 17720995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy.
    Balestrieri E; Grelli S; Matteucci C; Minutolo A; d'Ettorre G; Di Sora F; Montella F; Vullo V; Vella S; Favalli C; Macchi B; Mastino A
    J Med Virol; 2007 Feb; 79(2):111-7. PubMed ID: 17177302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of T cell immune responses in HIV-infected children from Uganda.
    Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
    J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.